Northern Institute for Cancer Research

Prognostic and predictive biomarker development

Prognostic and predictive biomarker development

About

We work in partnership with several biotechnology companies. We develop minimally-invasive, diagnostic and prognostic biomarker tests for prostate cancer patients.

Research Leaders

Rakesh Heer
Felicity May
Stuart McCracken
Kenny Rankin
Helen Reeves
Craig Robson
Ruchi Shukla
Gordon Strathdee

About

We are exploring biomarkers that reflect the key role of the cancer microenvironment in predicting prognosis and response to therapy. This will benefit patients with hepatocellular carcinoma.

We are also developing ‘liquid biopsy’ tools to help stratify and monitor therapies. 

We are creating genome-wide datasets. These help in the prognostication of leukaemia, and other adult cancer patient groups.

Staff